p27: A barometer of signaling deregulation and potential predictor of response to targeted therapies

Seth A. Wander, Dekuang Zhao, Joyce M. Slingerland

Research output: Contribution to journalArticle

111 Scopus citations

Abstract

Phosphorylation of the cyclin-dependent kinase inhibitor p27 by upstream mitogenic signaling pathways regulates its stability, localization, and biological function. In human cancers, loss of the antiproliferative action of p27 can arise through reduced protein levels and/or cytoplasmic mislocalization, leading to increased cell proliferation and/or cell migration, respectively. Reduced p27 expression levels and p27 mislocalization have potential prognostic and therapeutic implications in various types of human cancers. This review highlights mechanisms of functional deregulation of p27 by oncogenic signaling that provide an important molecular rationale for pathway targeting in cancer treatment.

Original languageEnglish (US)
Pages (from-to)12-18
Number of pages7
JournalClinical Cancer Research
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2011

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'p27: A barometer of signaling deregulation and potential predictor of response to targeted therapies'. Together they form a unique fingerprint.

  • Cite this